Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trial Optional)

The purpose of the High Impact Specialized Innovation Programs (SIPs) funded through the RC2 mechanism is to support the development and demonstration of high risk/high reward unique projects, capabilities, research platforms, infrastructure and/or resources to significantly advance clinical and translational science at awarded UM1 Clinical and Translational Science Award (CTSA) Program hubs. Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program hubs.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.